Beam Therapeutics Inc. · NASDAQ:BEAM
Emany Sravan Kumar received 31,750 Beam Therapeutics Inc. shares as an award (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Emany Sravan Kumar (Chief Financial Officer) received 31,750 Beam Therapeutics Inc. shares as an award, leaving 105,456 shares. Filed Apr 2, 2026 (Form 4).
- Awarded
- 31,750 shares
- Holding after
- 105,456 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Award | 31,750 | 105,456 | Direct |
Source
Related
- Beam Therapeutics Inc.
- Emany Sravan Kumar
- Beam Therapeutics Inc. shareholders
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026